EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Exogenous Glucagon-like Peptide 2 Counteracts Exogenous Cholecystokinin-induced Gallbladder Contraction in Healthy Men

Andreas H Lange, Nina L Hansen, Miriam G Pedersen, Henriette H Nerild, Jens F Rehfeld, Bolette Hartmann iD, Jens J Holst, Anne-Marie Ellegaard iD, Filip K Knop iD

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgae421 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Andreas H Lange und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Metabolic Research, Copenhagen University Hospital-Herlev and Gentofte, 2900 Hellerup, Denmark. Hauptthemen laut MEDLINE: Gallbladder, Glucagon-Like Peptide 2, Cholecystokinin, Gallbladder Emptying. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Hørslev-fonden, Savværksejer Jeppe Juhl og hustru Ovita Juhls Mindelegat, Novo Nordisk Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective Studies in humans and mice have demonstrated that the gut hormone glucagon-like peptide 2 (GLP-2) promotes gallbladder relaxation and refilling. Here, we assessed the effect of exogenous GLP-2 on gallbladder motility in the fasted state of healthy men with and without infusion of the potent gallbladder-contracting hormone cholecystokinin (CCK).

Methods

In a randomized, double-blind, placebo-controlled, crossover study, 15 male participants (mean [SD]: age 24.7 [3.6] years; body mass index 22.9 [1.6] kg/m2) underwent 4 experimental days receiving 2 infusions on each day: either CCK (0.4 pmol × kg−1 × min−1, time 0-180 minutes) + GLP-2 (10 pmol × kg−1 × min−1, time 30-240 minutes), CCK + placebo, placebo + GLP-2, or placebo + placebo, respectively. Gallbladder volume was measured at baseline and throughout the 4-hour study day using ultrasonography.

Results

Compared to placebo + placebo, GLP-2 + placebo did not affect gallbladder volume, but when infused in combination with CCK, GLP-2 completely abolished the strong gallbladder-contracting effect seen during CCK + placebo infusion, restoring baseline levels of gallbladder volume.

Conclusion

Exogenous GLP-2 counteracts exogenous CCK-induced gallbladder emptying in healthy men, pointing to a possible therapeutic potential for GLP-2 as a relaxing modulator of gallbladder smooth muscle tone (eg, as a bridge to surgery in biliary colic). The effect may also explain the gallbladder-related adverse events reported for GLP-2 receptor agonists used in the treatment of short bowel syndrome. Clinical Trial Registration number NCT04651868

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GallbladderGlucagon-Like Peptide 2CholecystokininGallbladder EmptyingCross-Over StudiesMuscle ContractionHealthy VolunteersHumansMaleDouble-Blind MethodAdultYoung Adult

Stichwörter der Autor:innen

CCKGLP-1GLP-2gallbladder

Substanzen

Glucagon-Like Peptide 2Cholecystokinin

Autor:innen und Institutionen

  • Center for Clinical Metabolic Research, Copenhagen University Hospital-Herlev and Gentofte, 2900 Hellerup, Denmark.
  • Department of Clinical Biochemistry, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
  • Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
  • Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.
  • Clinical Research, Steno Diabetes Center Copenhagen, 2730 Herlev, Denmark.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.

ORCID-Profile: Bolette Hartmann, Anne-Marie Ellegaard, Filip K Knop

Förderung

  • Hørslev-fonden
  • Savværksejer Jeppe Juhl og hustru Ovita Juhls Mindelegat
  • Novo Nordisk Foundation

Zitieren

APA

Lange, A. H., Hansen, N. L., Pedersen, M. G., Nerild, H. H., Rehfeld, J. F., Hartmann, B., Holst, J. J., Ellegaard, A. M., & Knop, F. K. (2024). Exogenous Glucagon-like Peptide 2 Counteracts Exogenous Cholecystokinin-induced Gallbladder Contraction in Healthy Men. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae421

Vancouver

Lange AH, Hansen NL, Pedersen MG, Nerild HH, Rehfeld JF, Hartmann B, et al. Exogenous Glucagon-like Peptide 2 Counteracts Exogenous Cholecystokinin-induced Gallbladder Contraction in Healthy Men. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgae421

BibTeX
@article{Lange2024,
  author = {Lange, Andreas H and Hansen, Nina L and Pedersen, Miriam G and Nerild, Henriette H and Rehfeld, Jens F and Hartmann, Bolette and Holst, Jens J and Ellegaard, Anne-Marie and Knop, Filip K},
  title = {Exogenous Glucagon-like Peptide 2 Counteracts Exogenous Cholecystokinin-induced Gallbladder Contraction in Healthy Men},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgae421}
}
Kostenlos starten →